The Group's principal activities are development, manufacture, acquisition, marketing and sale of technologically distinguished branded and generic or non-branded prescription pharmaceutical products. It operates through three segments, Branded Products Marketing, Specialty Generics Marketing and Specialty Raw Materials Marketing. It has developed and patented a wide variety of drug delivery and formulation technologies which are primarily focused in four principal areas: SITE RELEASE(R) bioadhesives; tastemasking; oral controlled release; and oral quick dissolving tablets. Currently, it owns more than 224 US and foreign trademarks.
Research Alerts:
Receive alerts on the latest reports on KV Pharmaceutical Company
Subscribe to Research Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
